Self-powered analyte sensor and devices using the same

Information

  • Patent Grant
  • 11229382
  • Patent Number
    11,229,382
  • Date Filed
    Friday, October 31, 2014
    9 years ago
  • Date Issued
    Tuesday, January 25, 2022
    2 years ago
Abstract
Systems, devices and methods for monitoring analyte levels using a self-powered analyte sensor and associated sensor electronics are provided.
Description
BACKGROUND

The detection and/or monitoring of glucose levels or other analytes, such as lactate, oxygen, A1C, or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.


Devices have been developed for the automatic monitoring of analyte(s), such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.


Measurement of analyte(s), such as glucose, by a monitoring device requires power. Current monitoring devices require an external power source to power the sensing circuitry and store the measured values in a memory for later retrieval by a display device.


SUMMARY

An analyte monitoring device in certain embodiments includes a self-powered analyte sensor having at least a portion in fluid contact with interstitial fluid under a skin surface, and sensor electronics operatively coupled to the self-powered analyte sensor, configured to receive signals generated by the self-powered analyte sensor, and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, the sensor electronics including: a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor, and a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level.


An analyte monitoring device in certain embodiments of the present disclosure includes a self-powered analyte sensor, and sensor electronics operatively coupled to the self-powered analyte sensor configured to receive signals generated by the self-powered analyte sensor and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, where the sensor electronics transitions from an inactive state to an active state when powered by a remote power source and upon receipt of a query signal from the remote power source, and in response to the query signal, communicates data corresponding to the generated signals associated with the monitored analyte level to the remote power source.


In certain embodiments, the self-powered analyte sensor is configured to continuously generate signals corresponding to monitored analyte level when in fluid contact with interstitial fluid.


In certain embodiments, the self-powered analyte sensor generates the signals corresponding to monitored analyte level when the sensor electronics are in the inactive state.


In certain embodiments, the sensor electronics are not operational when in the inactive state.


In certain embodiments, the sensor electronics include a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor.


In certain embodiments, the sensor electronics includes a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level.


In certain embodiments, the analyte monitoring device further includes a housing enclosing the self-powered sensor and the sensor electronics, wherein the housing is sealed to inhibit moisture from entering the housing.


In certain embodiments, the query signal includes an RFID signal.


In certain embodiments, the sensor electronics transition from the active state to the inactive state when the sensor electronics is not within the range of the remote power source.


In certain embodiments, the self-powered sensor is configured to generate the signals when in contact with the interstitial fluid and when the sensor electronics is in the inactive state.


In certain embodiments, the analyte monitoring device includes a housing enclosing the self-powered sensor and the sensor electronics, the housing including one or more mechanical components for physically detachably engaging with a remote device.


In certain embodiments, the remote device includes the remote power source.


In certain embodiments, the one or more mechanical components include one or more of a releasable latch, a releasable arm, or a releasable lock.


An analyte monitoring device, in certain embodiments, includes a self-powered analyte sensor having at least a portion in fluid contact with interstitial fluid under a skin surface, and sensor electronics operatively coupled to the self-powered analyte sensor configured to receive signals generated by the self-powered analyte sensor and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, the sensor electronics including: a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor; and a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level, where the sensor electronics transitions from an inactive state to an active state when powered by a remote power source and upon receipt of a query signal from the remote power source, and in response to the query signal, communicates data corresponding to the generated signals associated with the monitored analyte level to the remote power source.


In certain embodiments of the present disclosure, using the signals generated by the oxidation reaction of the self-powered sensor accumulated over time and stored in a capacitor device, sufficient charge is accumulated to drive the sensor electronics for processing signals related to the monitored analyte level, including storing, filtering, processing and communicating to a remote location. In this manner, sensor electronics coupled to the self-powered analyte sensor does not require a separate power source such as a battery to power the sensor electronics for processing signals related to the monitored analyte level including storing the generated and processed signals.


In some embodiments, a remote device such as a display device is configured to generate a magnetic field which, when positioned in close proximity to the sensor electronics, latches a switch in the sensor electronics to drive the charge stored in the sensor electronics capacitor device (generated from the self-powered sensor) to connect the remaining portions of the sensor electronics, effectively powering the sensor electronics solely from the charge stored in the capacitor that was generated by the self-powered sensor.


In a further embodiment, the self-powered sensor and sensor electronics are provided in a sealed housing and which does not include electronic components susceptible to sterilization processes for the sensor, and that would otherwise degrade or damage such electronic components. In this manner, in certain embodiments, a single enclosed housing including sensor electronics and the analyte sensor are provided which can be sterilized together using a single sterilization technique without damaging or degrading the components of the on body sensor device.


A method of monitoring analyte levels, in certain embodiments, includes transcutaneously positioning an analyte sensor in fluid contact with interstitial fluid under a skin surface, accumulating charge for a predetermined time period in a capacitor device in sensor electronics, the capacitor device in signal communication with the analyte sensor and receiving signals from the analyte sensor, detecting a magnetic field exceeding a threshold level, latching a switch provided in the sensor electronics to couple the capacitor device in the sensor electronics to sensor signal processing components when the detected magnetic field exceeds the threshold level, and connecting the capacitor device to the sensor signal processing components to provide power to the sensor signals processing components with the accumulated charge in the capacitor device.


A device for monitoring analyte level, in certain embodiments, includes an analyte sensor for transcutaneous positioning in fluid contact with interstitial fluid, sensor electronics including: sensor signal processing components, a capacitor device operatively coupled to the analyte sensor to accumulate charge for a predetermined time period, and a switch configured to latch, when a magnetic field exceeding a threshold level is detected, to couple the capacitor device to sensor signal processing components, where when the switch is latched, the capacitor device is configured to provide power to the sensor signals processing components with the accumulated charge in the capacitor device.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates an analyte monitoring system for real time analyte (e.g., glucose) measurement, data acquisition and/or processing in accordance with embodiments of the present disclosure;



FIG. 2 is a block diagram of an analyte monitoring system including a self-powered analyte sensor and RFID data communication module in accordance with embodiments of the present disclosure;



FIG. 3 illustrates the buffering circuit of the analyte monitoring system shown in FIG. 2 in accordance with embodiments of the present disclosure;



FIG. 4 illustrates the RFID circuit of the analyte monitoring system shown in FIG. 2 in accordance with embodiments of the present disclosure;



FIG. 5 illustrates an application specific integrated circuit (ASIC) which incorporates the RFID functionality of FIG. 4 in a single circuit in accordance with embodiments of the present disclosure;



FIG. 6 illustrates a sensor interface resistor capacitor (RC) network to interface between the self-powered sensor and the ASIC shown in FIG. 5 that incorporates the functions of the buffering circuit and the RFID circuit (shown in FIGS. 2-4) in accordance with certain embodiments of the present disclosure;



FIG. 7 is a graph comparing the results of a first calibration test measured by directly contacting the intervening resistor with a precision voltmeter, and a second calibration test obtained by remotely powering the RFID and buffering circuits through an external power source in accordance with embodiments of the present disclosure;



FIG. 8 illustrates a sealed, waterproof on body sensor electronics housing including the self-powered sensor, the buffering circuit and the RFID circuit and antenna described above in conjunction with FIGS. 2-5 in certain embodiments of the present disclosure;



FIG. 9 illustrates a sealed, waterproof on body sensor electronics housing including the self-powered sensor, the buffering circuit and the RFID circuit and antenna described above in conjunction with FIGS. 2-5, and further including a data communication component coupled to the on body sensor electronics housing in certain embodiments of the present disclosure;



FIG. 10 illustrates an analyte monitoring system including a self-powered analyte sensor, on body sensor electronics and reader device in accordance with embodiments of the present disclosure;



FIG. 11 illustrates an embodiment of the sensor electronics and self-powered analyte sensor of FIG. 10 in accordance with embodiments of the present disclosure;



FIG. 12 illustrates a fully implantable self-powered sensor and sensor electronics in accordance with certain embodiments of the present disclosure;



FIG. 13 is a flow chart illustrating a method of monitoring a level of an analyte of a user in accordance with embodiments of the present disclosure; and



FIG. 14 is a flow chart illustrating a method of monitoring a level of an analyte of a user in accordance with embodiments of the present disclosure.





DETAILED DESCRIPTION

Before the present disclosure is described in detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.


Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges as also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.


It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.


The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.


As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.


The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.



FIG. 1 shows an exemplary in vivo-based analyte monitoring system 100 in accordance with embodiments of the present disclosure. As shown, in certain embodiments, analyte monitoring system 100 includes on body electronics 110 electrically coupled to in vivo analyte sensor 101 (a proximal portion of which is shown in FIG. 1) and attached to adhesive layer 140 for attachment on a skin surface on the body of a user. On body electronics 110 includes on body housing 119, that defines an interior compartment. Also shown in FIG. 1 is insertion device 150 that, when operated, transcutaneously positions a portion of analyte sensor 101 through a skin surface and in fluid contact with ISF, and positions on body electronics 110 and adhesive layer 140 on a skin surface. In certain embodiments, on body electronics 110, analyte sensor 101 and adhesive layer 140 are sealed within the housing of insertion device 150 before use, and in certain embodiments, adhesive layer 140 is also sealed within the housing or itself provides a terminal seal of the insertion device 150. Devices, systems and methods that may be used with embodiments herein are described, e.g., in U.S. patent application Ser. No. 12/807,278, which published as U.S. Patent Application Publication No. 2011/0213225, the disclosure of which is incorporated herein by reference for all purposes.


Referring back to the FIG. 1, analyte monitoring system 100 includes display device 120 which includes a display 122 to output information to the user, an input component 121 such as a button, actuator, a touch sensitive switch, a capacitive switch, pressure sensitive switch, jog wheel or the like, to input data or command to display device 120 or otherwise control the operation of display device 120. It is noted that some embodiments may include display-less devices or devices without any user interface components. These devices may be functionalized to store data as a data logger and/or provide a conduit to transfer data from on body electronics and/or a display-less device to another device and/or location. Embodiments will be described herein as display devices for exemplary purposes which are in no way intended to limit the embodiments of the present disclosure. It will be apparent that display-less devices may also be used in certain embodiments.


In certain embodiments, on body electronics 110 may be configured to store some or all of the monitored analyte related data received from analyte sensor 101 in a memory during the monitoring time period, and maintain it in memory until the usage period ends. In such embodiments, stored data is retrieved from on body electronics 110 at the conclusion of the monitoring time period, for example, after removing analyte sensor 101 from the user by detaching on body electronics 110 from the skin surface where it was positioned during the monitoring time period. In such data logging configurations, real time monitored analyte level is not communicated to display device 120 during the monitoring period or otherwise transmitted from on body electronics 110, but rather, retrieved from on body electronics 110 after the monitoring time period.


In certain embodiments, input component 121 of display device 120 may include a microphone and display device 120 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 120 may be controlled by voice commands. In certain embodiments, an output component of display device 120 includes a speaker for outputting information as audible signals. Similar voice responsive components such as a speaker, microphone and software routines to generate, process and store voice driven signals may be provided to on body electronics 110.


In certain embodiments, display 122 and input component 121 may be integrated into a single component, for example a display that can detect the presence and location of a physical contact touch upon the display such as a touch screen user interface. In such embodiments, the user may control the operation of display device 120 by utilizing a set of pre-programmed motion commands, including, but not limited to, single or double tapping the display, dragging a finger or instrument across the display, motioning multiple fingers or instruments toward one another, motioning multiple fingers or instruments away from one another, etc. In certain embodiments, a display includes a touch screen having areas of pixels with single or dual function capacitive elements that serve as LCD elements and touch sensors.


Display device 120 also includes data communication port 123 for wired data communication with external devices such as remote terminal (personal computer) 170, for example. Example embodiments of the data communication port 123 include USB port, mini USB port, RS-232 port, Ethernet port, Firewire port, or other similar data communication ports configured to connect to the compatible data cables. Display device 120 may also include an integrated in vitro glucose meter, including in vitro test strip port 124 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.


Referring still to FIG. 1, display 122 in certain embodiments is configured to display a variety of information—some or all of which may be displayed at the same or different time on display 122. In certain embodiments the displayed information is user-selectable so that a user can customize the information shown on a given display screen. Display 122 may include but is not limited to graphical display 138, for example, providing a graphical output of glucose values over a monitored time period (which may show important markers such as meals, exercise, sleep, heart rate, blood pressure, etc.), numerical display 132, for example, providing monitored glucose values (acquired or received in response to the request for the information), and trend or directional arrow display 131 that indicates a rate of analyte change and/or a rate of the rate of analyte change, e.g., by moving locations on display 122.


As further shown in FIG. 1, display 222 may also include date display 135 providing for example, date information for the user, time of day information display 139 providing time of day information to the user, battery level indicator display 133 which graphically shows the condition of the battery (rechargeable or disposable) of the display device 120, sensor calibration status icon display 134 for example, in monitoring systems that require periodic, routine or a predetermined number of user calibration events, notifying the user that the analyte sensor calibration is necessary, audio/vibratory settings icon display 136 for displaying the status of the audio/vibratory output or alarm state, and wireless connectivity status icon display 137 that provides indication of wireless communication connection with other devices such as on body electronics, data processing module 160, and/or remote terminal 170. As additionally shown in FIG. 1, display 122 may further include simulated touch screen buttons 125, 126 for accessing menus, changing display graph output configurations or otherwise for controlling the operation of display device 120.


Referring back to FIG. 1, in certain embodiments, display 122 of display device 120 may be additionally, or instead of visual display, configured to output alarm notifications such as alarm and/or alert notifications, glucose values etc, which may be audible, tactile, or any combination thereof. In one aspect, the display device 120 may include other output components such as a speaker, vibratory output component and the like to provide audible and/or vibratory output indication to the user in addition to the visual output indication provided on display 122. Further details and other display embodiments can be found in, e.g., U.S. patent application Ser. No. 12/871,901, U.S. provisional application Nos. 61/238,672, 61/247,541, 61/297,625, the disclosures of each of which are incorporated herein by reference for all purposes.


After the positioning of on body electronics 110 on the skin surface and analyte sensor 101 in vivo to establish fluid contact with ISF (or other appropriate body fluid), on body electronics 110 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 110 receives a command or request signal from display device 120. In certain embodiments, on body electronics 110 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 120 when display device 120 is within communication range of the data broadcast from on body electronics 110, i.e., it does not need a command or request from a display device to send information.


For example, display device 120 may be configured to transmit one or more commands to on body electronics 110 to initiate data transfer, and in response, on body electronics 110 may be configured to wirelessly transmit stored analyte related data collected during the monitoring time period to display device 120. Display device 120 may in turn be connected to a remote terminal 170 such as a personal computer and functions as a data conduit to transfer the stored analyte level information from the on body electronics 110 to remote terminal 170. In certain embodiments, the received data from the on body electronics 110 may be stored (permanently or temporarily) in one or more memory of the display device 120. In certain other embodiments, display device 120 is configured as a data conduit to pass the data received from on body electronics 110 to remote terminal 170 that is connected to display device 120.


Referring still to FIG. 1, also shown in analyte monitoring system 100 are data processing module 160 and remote terminal 170. Remote terminal 170 may include a personal computer, a server terminal a laptop computer or other suitable data processing devices including software for data management and analysis and communication with the components in the analyte monitoring system 100. For example, remote terminal 170 may be connected to a local area network (LAN), a wide area network (WAN), or other data network for uni-directional or bi-directional data communication between remote terminal 170 and display device 120 and/or data processing module 160.


Remote terminal 170 in certain embodiments may include one or more computer terminals located at a physician's office or a hospital. For example, remote terminal 170 may be located at a location other than the location of display device 120. Remote terminal 170 and display device 120 could be in different rooms or different buildings. Remote terminal 170 and display device 120 could be at least about one mile apart, e.g., at least about 10 miles apart, e.g., at least about 100 miles apart. For example, remote terminal 170 could be in the same city as display device 120, remote terminal 170 could be in a different city than display device 120, remote terminal 170 could be in the same state as display device 120, remote terminal 170 could be in a different state than display device 120, remote terminal 170 could be in the same country as display device 120, or remote terminal 170 could be in a different country than display device 120, for example.


In certain embodiments, a separate, optional data communication/processing device such as data processing module 160 may be provided in analyte monitoring system 100. Data processing module 160 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth® protocol, Zigbee® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth® protocol and/or Zigbee® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes. Data processing module 160 may further include communication ports, drivers or connectors to establish wired communication with one or more of display device 120, on body electronics 110, or remote terminal 170 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.


In certain embodiments, data processing module 160 is programmed to transmit a polling or query signal to on body electronics 110 at a predetermined time interval (e.g., once every minute, once every five minutes, or the like), and in response, receive the monitored analyte level information from on body electronics 110. Data processing module 160 stores in its memory the received analyte level information, and/or relays or retransmits the received information to another device such as display device 120. More specifically in certain embodiments, data processing module 160 may be configured as a data relay device to retransmit or pass through the received analyte level data from on body electronics 110 to display device 120 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.


In certain embodiments, on body electronics 110 and data processing module 160 may be positioned on the skin surface of the user within a predetermined distance of each other (for example, about 1-12 inches, or about 1-10 inches, or about 1-7 inches, or about 1-5 inches) such that periodic communication between on body electronics 110 and data processing module 160 is maintained. Alternatively, data processing module 160 may be worn on a belt or clothing item of the user, such that the desired distance for communication between the on body electronics 110 and data processing module 160 for data communication is maintained. In a further aspect, the housing of data processing module 160 may be configured to couple to or engage with on body electronics 110 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface. In further embodiments, data processing module 160 is detachably engaged or connected to on body electronics 110 providing additional modularity such that data processing module 160 may be optionally removed or reattached as desired.


Referring again to FIG. 1, in certain embodiments, data processing module 160 is programmed to transmit a command or signal to on body electronics 110 at a predetermined time interval such as once every minute, or once every 5 minutes or once every 30 minutes or any other suitable or desired programmable time interval to request analyte related data from on body electronics 110. When data processing module 160 receives the requested analyte related data, it stores the received data. In this manner, analyte monitoring system 100 may be configured to receive the continuously monitored analyte related information at the programmed or programmable time interval, which is stored and/or displayed to the user. The stored data in data processing module 160 may be subsequently provided or transmitted to display device 120, remote terminal 170 or the like for subsequent data analysis such as identifying frequency of periods of glycemic level excursions over the monitored time period, or the frequency of the alarm event occurrence during the monitored time period, for example, to improve therapy related decisions. Using this information, the doctor, healthcare provider or the user may adjust or recommend modification to the diet, daily habits and routines such as exercise, and the like.


In another embodiment, data processing module 160 transmits a command or signal to on body electronics 110 to receive the analyte related data in response to a user activation of a switch provided on data processing module 160 or a user initiated command received from display device 120. In further embodiments, data processing module 160 is configured to transmit a command or signal to on body electronics 110 in response to receiving a user initiated command only after a predetermined time interval has elapsed. For example, in certain embodiments, if the user does not initiate communication within a programmed time period, such as, for example about 5 hours from last communication (or 10 hours from the last communication, or 24 hours from the last communication), the data processing module 160 may be programmed to automatically transmit a request command or signal to on body electronics 110. Alternatively, data processing module 160 may be programmed to activate an alarm to notify the user that a predetermined time period of time has elapsed since the last communication between the data processing module 160 and on body electronics 110. In this manner, users or healthcare providers may program or configure data processing module 160 to provide certain compliance with analyte monitoring regimen, so that frequent determination of analyte levels is maintained or performed by the user.


In certain embodiments, when a programmed or programmable alarm condition is detected (for example, a detected glucose level monitored by analyte sensor 101 that is outside a predetermined acceptable range indicating a physiological condition which requires attention or intervention for medical treatment or analysis (for example, a hypoglycemic condition, a hyperglycemic condition, an impending hyperglycemic condition or an impending hypoglycemic condition), the one or more output indications may be generated by the control logic or processor of the on body electronics 110 and output to the user on a user interface of on body electronics 110 so that corrective action may be timely taken. In addition to or alternatively, if display device 120 is within communication range, the output indications or alarm data may be communicated to display device 120 whose processor, upon detection of the alarm data reception, controls the display 122 to output one or more notification.


In certain embodiments, control logic or microprocessors of on body electronics 110 include software programs to determine future or anticipated analyte levels based on information obtained from analyte sensor 101, e.g., the current analyte level, the rate of change of the analyte level, the acceleration of the analyte level change, and/or analyte trend information determined based on stored monitored analyte data providing a historical trend or direction of analyte level fluctuation as function time during monitored time period. Predictive alarm parameters may be programmed or programmable in display device 120, or the on body electronics 110, or both, and output to the user in advance of anticipating the user's analyte level reaching the future level. This provides the user an opportunity to take timely corrective action.


Information, such as variation or fluctuation of the monitored analyte level as a function of time over the monitored time period providing analyte trend information, for example, may be determined by one or more control logic or microprocessors of display device 120, data processing module 160, and/or remote terminal 170, and/or on body electronics 110. Such information may be displayed as, for example, a graph (such as a line graph) to indicate to the user the current and/or historical and/or and predicted future analyte levels as measured and predicted by the analyte monitoring system 100. Such information may also be displayed as directional arrows (for example, see trend or directional arrow display 131) or other icon(s), e.g., the position of which on the screen relative to a reference point indicated whether the analyte level is increasing or decreasing as well as the acceleration or deceleration of the increase or decrease in analyte level. This information may be utilized by the user to determine any necessary corrective actions to ensure the analyte level remains within an acceptable and/or clinically safe range. Other visual indicators, including colors, flashing, fading, etc., as well as audio indicators including a change in pitch, volume, or tone of an audio output and/or vibratory or other tactile indicators may also be incorporated into the display of trend data as means of notifying the user of the current level and/or direction and/or rate of change of the monitored analyte level. For example, based on a determined rate of glucose change, programmed clinically significant glucose threshold levels (e.g., hyperglycemic and/or hypoglycemic levels), and current analyte level derived by an in vivo analyte sensor, the system 100 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs increasing in intensity or the like.


Referring again back to FIG. 1, in certain embodiments, software algorithm(s) for execution by data processing module 160 may be stored in an external memory device such as an SD card, micro-SD card, compact flash card, XD card, Memory Stick card, Memory Stick Duo card, or USB memory stick/device including executable programs stored in such devices for execution upon connection to the respective one or more of the on body electronics 110, remote terminal 170 or display device 120. In a further aspect, software algorithms for execution by data processing module 160 may be provided to a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device.


Examples of smart phones include Windows®, Android™, iPhone® operating system, Palm® WebOS™, Blackberry® operating system, or Symbian® operating system based mobile telephones with data network connectivity functionality for data communication over an internet connection and/or a local area network (LAN). PDAs as described above include, for example, portable electronic devices including one or more microprocessors and data communication capability with a user interface (e.g., display/output unit and/or input unit, and configured for performing data processing, data upload/download over the internet, for example. In such embodiments, remote terminal 170 may be configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 170 and the devices are established.


In still further embodiments, executable software applications may be provided over-the-air (OTA) as an OTA download such that wired connection to remote terminal 170 is not necessary. For example, executable applications may be automatically downloaded as software download to the communication device, and depending upon the configuration of the communication device, installed on the device for use automatically, or based on user confirmation or acknowledgement on the communication device to execute the installation of the application. The OTA download and installation of software may include software applications and/or routines that are updates or upgrades to the existing functions or features of data processing module 160 and/or display device 120.


Referring back to remote terminal 170 of FIG. 1, in certain embodiments, new software and/or software updates such as software patches or fixes, firmware updates or software driver upgrades, among others, for display device 120 and/or on body electronics 110 and/or data processing module 160 may be provided by remote terminal 170 when communication between the remote terminal 170 and display device 120 and/or data processing module 160 is established. For example, software upgrades, executable programming changes or modification for on body electronics 110 may be received from remote terminal 170 by one or more of display device 120 or data processing module 160, and thereafter, provided to on body electronics 110 to update its software or programmable functions. For example, in certain embodiments, software received and installed in on body electronics 110 may include software bug fixes, modification to the previously stalled software parameters (modification to analyte related data storage time interval, resetting or adjusting time base or information of on body electronics 110, modification to the transmitted data type, data transmission sequence, or data storage time period, among others).


Further embodiments, details and configurations of the analyte monitoring system can be found in U.S. patent application Ser. No. 12/807,278, which published as U.S. Patent Application Publication No. 2011/0213225, the disclosure of which is incorporated herein by reference for all purposes.



FIG. 2 is a block diagram of an analyte monitoring system including a self-powered analyte sensor and RFID data communication module in accordance with one embodiment of the present disclosure. As shown in FIG. 2, in certain embodiments, the analyte monitoring system 200 includes self-powered sensor 210 operatively coupled to buffering circuit 220 that is further provided in signal communication with RFID circuit 230. The self-powered sensor 210, the buffering circuit 220 and the RFID circuit 230 in certain embodiments may be provided in a single on body sensor electronics housing, with a portion of the self-powered sensor 210 positioned under the skin surface of a user and in fluid contact with interstitial fluid. The single on body sensor electronics housing in certain embodiments is a waterproof housing. Referring back to FIG. 2, also shown is an external power source and Reader device (“reader”) 240 which in certain embodiments, includes an RFID reader that is capable of radiating an RF field, and when in proximity to an RFID device, receives data communication back from the RFID device using the RF field.


In certain embodiments, self-powered sensor 210 includes at least a working electrode and a counter electrode and power is generated as a result of the oxidation reaction between the working and counter electrodes. Additional details on the structure, operation and configurations of self-powered sensor 210 can be found in U.S. patent application Ser. No. 12/393,921, published as US 2010/0213057, U.S. patent application Ser. No. 13/087,190 published as US 2011/0257495, and U.S. patent application Ser. No. 13/299,119 published as US 2012-0157801, the disclosures of each of which are incorporated herein by reference for all purposes.


For example, in certain embodiments, self-powered sensor 210 generates an average current of about 10 nA to about 100 nA with an average voltage of about 100 mV to about 300 mV, resulting in an average power output of about 1 nW to 30 nW. It is to be understood that the current, voltage and power ranges described herein are representative and the disclosure is not limited to the ranges mentioned herein. In certain embodiments, a low current may be desired for the electrode pair utilized for measuring analyte levels. In such embodiments, a second working electrode and counter electrode pair may be included in the self-powered sensor 210, and be configured for higher current output for power generation.


Referring to FIG. 2, in certain embodiments, the self-powered sensor 210 operates continuously, without the use of an external power source, to generate current signals that are proportional to the analyte concentration in the bodily fluid that the self-powered sensor 210 is placed in contact therewith. The RFID circuit 230 and the buffering circuit 220, in certain embodiments, remain dormant or in an inactive or nonoperational state while the self-powered sensor 210 is generating the current signals. In certain embodiments, when Reader 240 is positioned in close proximity to the RFID circuit 230 of the on body sensor electronics such that the RFID circuit 230 is within the RF field radiated from the Reader 240, the RFID circuit is configured to query the self-powered sensor 210 through the buffering circuit 220 to receive the measured sensor current signal, and sends or returns the measured sensor current signal (received from the self-powered sensor 210 via the buffering circuit 220) to the Reader 240. As described further below and also shown in FIG. 6, self-powered sensor 210, in certain embodiments, is connected to an R/C (resistor/capacitor) load providing a return current path for self-powered sensor 210. Measured voltage across the R/C load generated when the generated current flows through the R/C load, provides one or more signals which is passed (through the buffering circuit 220) to the RFID circuit 230. In certain embodiments, the signals communicated by the RFID circuit 230 in response to the query from the Reader 240 include analog signals generated by the self-powered sensor corresponding to the monitored analyte levels digitized for data transmission, measured temperature data, and calibration code information.



FIG. 3 illustrates the buffering circuit 220 of the analyte monitoring system 200 shown in FIG. 2 in accordance with embodiments of the present disclosure. As shown, buffering circuit 220 shown in FIG. 3 is an instrumentation operational amplifier (OPA) used to isolate the self-powered sensor 210 (FIG. 2) from the RFID circuit 230 (FIG. 2). The input buffers may include one or more operational amplifiers with high impedance to isolate the signals from the self-powered sensor 210 from the RFID circuit 230, and maintain the accuracy of the monitored analyte level readings generated by the self-powered sensor 210. In certain embodiments the buffering circuit 220 is a close to unity gain amplifier and passes the analog voltage signals to RFID circuit 230.



FIG. 4 illustrates the RFID circuit 230 of the analyte monitoring system shown in FIG. 2 in accordance with embodiments of the present disclosure. Referring to FIG. 4, the RFID circuit 230 in certain embodiments includes an antenna and an RFID chip. The RFID circuit 230 also includes a voltage reference used to raise the bias potential for the buffering circuit 220 and for the analog front end circuitry of the RFID chip, as well as a precision voltage regulator. In operation, when the Reader 240 is positioned in close proximity to the RFID circuit 230, the RF field radiated from the Reader 240 provides the necessary power to operate the buffering circuit 220 and the RFID circuit 230. Further, signals received from the Reader 240 initialize the RFID circuit 230 by resetting the digital circuits and setting the digital bits of the memory and registers of the RFID circuit 230. RFID query commands are sent to the RFID circuit 230, and in response, the RFID circuit 230 transmits the digitized signals associated with the monitored analyte level to the Reader 240.



FIG. 5 illustrates an application specific integrated circuit (ASIC) which incorporates the function of the RFID circuit shown in FIG. 4 and the function of the buffering circuit 220 shown in FIG. 3 in a single ASIC configuration 500. In certain embodiments, ASIC 500 includes an ISO 15693 RFID front-end circuitry, a magnetic field energy saving circuit, DC power management (regulators), sensor digital control, analog to digital and digital to analog converters and an analog front end circuitry. An IOS 15963 RFID front-end circuitry provides wireless access for Reader 240 to acquire digitized data from the ASIC 500. A magnetic field energy saving circuit converts the magnetic field energy received from the Reader 240 to DC power to supply power to the ASIC 500 when Reader 240 is in proximity. A DC power management circuit utilizes the DC power generated at the magnetic field energy saving circuit to provide stable and filtered DC power for the ASIC 500. A sensor digital control circuit initializes and programs ASIC 500, controls the analog to digital processing and analog front end gain, and provides digitized data to the RFID front-end circuitry. An analog to digital converter (ADC) converts the analog signals to a corresponding digital signal for the RFID front-end backscatter modulation and a digital to analog converter (DAC) is used to compensate error due to analog front end offset voltage. An analog front end circuitry amplifies the analog signals received from self-powered sensor 210 for ADC conversion.



FIG. 6 illustrates a sensor interface resistor capacitor (RC) network to interface between the self-powered sensor 210 and the ASIC shown in FIG. 5 that incorporates the functions of the buffering circuit 220 and the RFID circuit 230 (shown in FIGS. 2-4) in accordance with certain embodiments of the present disclosure. In particular, in certain embodiments, a resistor bridge circuit with two resistor arms 600 is provided between the ASIC 500 of FIG. 5 with the self-powered sensor 210. The resistor bridge circuit provides bias for both inputs of the ASIC 500 and allows for maintenance of accuracy of the analyte measurement signal even at low current levels. The voltage across the ASIC input terminals D_in1, D_in2 is the sensor voltage across resistor R to be proportional to the sensor current received from the self-powered sensor 210. The bias voltage provided to both input arms of the ASIC 500 maintains a constant differential voltage for a given resistance. An R/C sensor load is connected in parallel with self-powered sensor 210 and in series between the bridge circuit and one input of the ASIC 500. The voltage variations across the R/C load applies to the differential voltage between the two inputs of the ASIC 500 and corresponds to the sensor measurement signal received by the ASIC 500. The resistor bridge further provides a compensation voltage to cancel any leakage current effect when there is bias current flowing out or in through the inputs of the ASIC 500.



FIG. 7 is a graph comparing the results of a first calibration test measured by directly contacting the intervening resistor with a precision voltmeter, and a second calibration test obtained by remotely powering the RFID and buffering circuits through an external power source. Referring to FIG. 7, the test included a self-powered sensor with a glucose oxide anode and a carbon cathode and an intervening 5MΩ resistor. The self-powered sensor was immersed in a buffer solution and glucose aliquots were added. The test was repeated (1) for a directly contacted intervening resistor and (2) by remotely powering RFID and buffering circuits. Self-powered sensor and corresponding circuitry configurations were tested to determine the accuracy and potential for signal loss by utilizing RFID communication versus direct contact communication. The test configurations had an external power source attached thereto to test the calibration of the test configurations.



FIG. 8 illustrates a sealed, waterproof on body sensor electronics housing 800 including the self-powered sensor, the buffering circuit and the RFID circuit and antenna described above in conjunction with FIGS. 2-5 in certain embodiments of the present disclosure. Referring to FIG. 8, a portion of the self-powered sensor extends from the sealed on body sensor electronics housing, and upon positioning of the sensor electronics housing, the sensor portion that extends from the housing is positioned under the skin surface and in contact with the interstitial fluid. In this manner, in certain embodiments, the sealed sensor electronics housing including sensor electronics such as the buffering circuit and the RFID circuit can be sterilized with gamma ray or e-bam radiation as the housing does not include a memory device that may be susceptible to such sterilization.



FIG. 9 illustrates a sealed, waterproof on body sensor electronics housing 900 including the self-powered sensor, the buffering circuit and the RFID circuit and antenna described above in conjunction with FIGS. 2-5, and further including a data communication device 910 coupled to the on body sensor electronics housing in certain embodiments of the present disclosure. Referring to FIG. 9, the sealed on-body sensor electronics housing may be coupled with a data communication device that may be reversibly snapped onto the sealed sensor electronics housing, or alternatively detachably attached with mechanical features such as grooves, latches, locks arms and the like.


The data communication device in certain embodiments includes RFID power source and reader device, and alternatively, also include an RF data communication module. In certain embodiments, the RFID power source and reader device may be programmed or is programmable to query the sensor electronics to retrieve sensor signals corresponding to monitored analyte level at a predetermined or programmed or programmable time interval, which, upon receipt, may also retransmit or communicate the received sensor signals to a remote location, for example, using the RF data communication module within the data communication device. In certain embodiments, alarms and projected measurement values can be determined based upon the stored analyte level measurements. In certain embodiments, the data communication device may be powered separately and remotely for extended life.


In the manner described above, self-powered sensor is configured to operate with a buffering circuit and RFID circuit, where upon receipt of a query signal from the Reader device (that provides RF field), the RFID circuit and the buffer circuit transition into active operational mode to retrieve the sensor signal from the self-powered sensor and to provide data related to monitored analyte level corresponding to the retrieved sensor signal to the Reader device. Further, in certain embodiments of the present disclosure, self-powered sensor and electronics assembly are provided in a single waterproof housing that meets or exceeds IPX-7 level, which can be sterilized using a single sterilization technique without potential damage to the assembly since the assembly does not include a memory device that may be susceptible to the suitable gamma ray or e-beam sterilization.



FIG. 10 illustrates an analyte monitoring system including a self-powered analyte sensor, on body sensor electronics and reader device in accordance with embodiments of the present disclosure. Referring to FIG. 10, sensor electronics 110 includes a capacitor 1021 and resistor 1022, wherein the voltage 1012 generated by the analyte sensor runs through the resistor 1022 to charge capacitor 1021 which stores charge resulting in the current signals generated by the self-powered analyte sensor 101. Capacitor 1021 is sized to store sufficient charge to power sensor electronics 110 for a time period sufficient to measure and store analyte values monitored by the analyte sensor, without the use of any external power supply such as a battery. In certain embodiments, the sensor electronics 110 includes a switch 1023. Switch 1023, when activated, switches or latches the power loop from charging the capacitor 1021 via the self-powered analyte sensor 101, to a circuit loop whereby the capacitor 1021 discharges to flow through a power management module 1025, which in certain embodiments, includes a voltage multiplier to increase the voltage from capacitor 1021 to a sufficiently high voltage for operation of sensor electronics 110 to read and store a measured analyte value. For example, in certain embodiments, for operation of the sensor electronics 110, approximately 500 mV is used as the minimum charging input voltage from the sensor, and the 500 mV is doubled in the power management module 1025 to power on sensor electronics circuits.


Sensor electronics 110 for measurement, processing and storage of signals corresponding to monitored analyte level includes power management module 1025, a sensor input buffer 1026, control circuits 1027, an analog-to-digital (A/D) converter 1028, a memory 1029 and a data output module 1030. In certain embodiments, power management module 1025 is configured to multiply, regulate and detect the charge stored or accumulated in capacitor 1021 before powering the entire sensor circuitry of sensor electronics 110. Sensor input buffer 1026 includes an instrumental operational amplifier of high impedance and a resistor bridge network, which acts as a buffer between analyte sensor 101 and A/D converter 1028. The resistor bridge provides reference voltage (Vcc/2) for the inputs of the instrumental operation amplifier. One of the arms of the resistor bridge is connected to input of the instrumental operation amplifier through a sensor load R/C circuit.


Sensor input buffer 1026 is used due to the low analyte current level generated at analyte sensor corresponding to the measurement of an analyte level, to minimize the impact on the analyte current measurement. Since the input impedance of the instrumental operation amplifier is very high, the sensor current will not flow (through) in or out of the inputs of the instrumental amplifier when the sensor is connected. Thus, the sensor current measurement will not be affected by the external circuits connected to the sensor.


A/D converter 1028 converts the analog analyte current signals from analyte sensor 101 via the signal input buffer 1026, to a digital value to be stored on memory 1029. Data output module 1030 is utilized to transmit, either via direct contact or wirelessly, data stored on memory 1029 to display device 120 or other electronic device with a compatible physical and/or wireless input port.


Control circuits 1027 control the signal flow among the various sensor electronics 110 components, including the sensor input buffer 1026, A/D converter 1028, memory 1029, and data output module 1030. In certain embodiments, control circuit 1027 is configured to initialize digital settings and start measurement, to control the gain of the instrumental operation amplifier to provide amplified analog signal for A/D converter 1028, and to store the converted digital data into memory 1029 and upload the data from the memory 1029 to display device 120.


In certain embodiments, sensor electronics 110 uses approximately 100 μW for approximately 100 ms (approximately 10 microjoules) to measure and store an analyte measurement. Self-powered analyte sensor 101, in certain embodiments, generates approximately 25 nW, which would take approximately 400 s (7 minutes) to accumulate the 10 microjoules necessary to measure and store the analyte measurement. In such embodiments, the analyte monitoring system 100 can be configured to measure and store an analyte measurement at least every 7 minutes without the need of a battery or other external power source.


Still referring to FIG. 10, and as illustrated in FIG. 1, analyte monitoring system 100 includes display device 120. Display device 120 may be configured to transmit a signal to the sensor electronics 110 to activate switch 1023 to begin measurement and storage of an analyte value. In certain embodiments, display device 120 may include a magnetic field generator 1041, and switch 1023 may be a magnetic switch, where upon activation of the magnetic field generator 1041, the magnetic switch switches operation of sensor electronics 110 from charging the capacitor 1021 to measurement and storage of an analyte value. Switch 1023 is connected to sensor 101 through R1, which limits the charging current, before magnetic field presents next to it. In such way, the sensor will charge the capacitor 1021 in most time. Since the sensor can only generate ultra-low current, it will take a long time to fully charge the capacitor 1021. The magnetic field generator 1041 in certain embodiments includes conductive wire loops and soft iron. The magnetic field is generated with a current from a direct current (DC) current source 1043 flowing through the conductive wire loops, while the soft iron enhances the magnetic field.


In further embodiments, sensor electronics 110 also includes a wire loop 1024, which, upon detection of current flowing through the wire loop 1024 due to magnetic switching of switch 1023, generates a magnetic pulse signal. The magnetic pulse signal is detected by the display device 120 to confirm that the magnetic actuation of the switch 1023 and confirm the magnetic field generator 1041 signal was received at the sensor electronics 110. When switch 1023 is connected to wire loop 1024, the initial pulse signal in the form of the magnetic field will disturb the magnetic field produced by the magnetic field generator 1041. The magnetic field will cause current change across the conductive loop wire 1024. The sensor-on detector 1044 will detect the current changes to confirm the switch 1023 status change.


In certain embodiments, the magnetic pulse signal is detected by a sensor-on detector 1044 of the display device 120. The display device 1042 displays how many times the user activates the sensor electronics 110, and the day and time information from the last activation time. Since the capacitor 1021 charging will take a certain amount of time, activation spaced too close together will not provide sufficient time for capacitor 1021 to be fully charged. In certain embodiments, microprocessor 1045 is configured to turn on DC current generator 1043, detect sensor-on detector 1044 status, monitor battery voltage, download the data from sensor electronics 110 and operate the display device 1042. Display device 120 may further include a display 1042, microprocessor 1045, data input module 1046 and battery 1047.



FIG. 11 illustrates an embodiment of the sensor electronics 110 and self-powered analyte sensor 101 of FIG. 10. Referring to FIG. 11, self-powered analyte sensor 101 and sensor electronics 110 including wire loop 1024, magnetic switch 1023, capacitor 1021, resistor 1022, a physical data output 1030 and electronics 1020 including power management module 1025, sensor input buffer 1026, control circuits 1027, A/D converter 1028 and memory 1029 are integrated into a single device. In other embodiments, analyte sensor 101 is separate from the sensor electronics 110 and is physically and/or electrically coupled with the sensor electronics 110 before, during or after transcutaneous insertion through the skin surface.


In other embodiments, sensor electronics 110 components are located on two or more separate devices. For example, in certain embodiments, a first device may include analyte sensor 101 integrated with sensor electronics 110 components including wire loop 1024, switch 1023, capacitor 1021, resistor 1022 and physical data output 1030, while a second device which is configured to be physically coupled to the first device, includes electronics 1020 including power management module 1025, sensor input buffer, 1026, control circuits 1027, A/D converter 1028 and memory 1029. The second device may include a physical data input that is physically coupled with physical data output 1030 to facilitate transfer of data and signals between the first and second device. Further, second device may further include an output, either physical contacts or wireless communication, such as radio frequency (RF), which communicates with display device 120.



FIG. 12 illustrates a fully implantable self-powered sensor and sensor electronics in accordance with certain embodiments of the present disclosure. In certain embodiments, self-powered sensor 1210 and sensor electronics including buffer circuit 1220, RFID circuit 1230 and antenna 1240 are provided in a sealed housing 1200 and configured to be fully implantable under skin surface 1290. As described in detail above, self-powered sensor 1210 and sensor electronics are configured to be externally powered via magnetic field provided by Reader 1250. In this manner, in certain embodiments, self-powered sensor 1210 and sensor electronics to be configured for long-term implantation beneath a skin surface 1290 of a user. In certain embodiments, implantable self-powered sensor 1210 receives an RF signal 1270 request from Reader 1250, and transmits a return RF signal 1280 for receipt at the Reader antenna 1260. Return RF signal 1280 includes the sensor data measured by the self-powered sensor 1210. In certain embodiments, sensor electronics may be a single ASIC within the sealed housing 1200.



FIG. 13 is a flow chart illustrating analyte monitoring in certain embodiments of the present disclosure. Referring to FIG. 13, after transcutaneous positioning of a self-powered analyte sensor (1310), the oxidation reaction between the working and counter electrodes of the self-powered analyte sensor generates current signals that is then used by the sensor electronics to charge a capacitor for powering the sensor electronics (1320). Referring back to FIG. 13, periodically, the sensor electronics receive a signal to measure a current analyte level (1330). In certain embodiments, the signal is generated automatically at periodic intervals, and in other embodiments, the signal is generated based on a command from a display device. Upon receipt of the signal, a switch in the sensor electronics is activated, which switches the flow of power between the self-powered sensor and capacitor to discharge the capacitor to power the sensor electronics (1340). Upon activation of the sensor electronics, the current signal measured at the self-powered sensor representative of a current analyte level is detected by the sensor electronics (1350). The measured current signal of the self-powered sensor is converted to a digital value (1360) by the A/D converter of the sensor electronics. The digital value is then stored in memory (1370) for later retrieval or transmission to a display device.



FIG. 14 is a flow chart illustrating analyte monitoring in certain embodiments of the present disclosure. As shown in FIG. 14, after transcutaneous positioning of a self-powered analyte sensor (1410), the oxidation reaction between the working and counter electrodes of the self-powered analyte sensor generates current signals. The generated current signals are used by the sensor electronics to charge a capacitor for storage of power for powering the sensor electronics (1420). Periodically, the sensor electronics detect a signal generated by a magnetic field generator corresponding to a command to measure a current analyte level (1430). Upon receipt of the magnetic field generated signal, the magnetic switch in the sensor electronics is activated, which switches the flow of power between the self-powered sensor and capacitor to discharge the capacitor to power the sensor electronics (1440). The reversed flow from the capacitor flows through a wire loop, which in turn generates a magnetic field signal indicative of a verification of connection of the magnetic switch. Upon activation of the magnetic switch, and subsequent activation of the sensor electronics, the current signal measured at the self-powered sensor representative of a current analyte level is detected by the sensor electronics (1450). The measured current signal of the self-powered sensor is converted to a digital value (1460) by the A/D converter of the sensor electronics. The digital value is then stored in memory (1470) for later retrieval or transmission to a display device.


In the manner described above, in accordance with embodiments of the present disclosure, solely using the signals generated by the oxidation reaction of the self-powered sensor, the generated signals provide sufficient power to drive the sensor electronics for processing signals related to the monitored analyte level, including storing, filtering, processing and for communication to a remote location. In this manner, in certain embodiments, sensor electronics coupled to the self-powered analyte sensor does not require a separate power source such as a battery to power the sensor electronics for processing signals related to the monitored analyte level including storing the generated and processed signals. In further embodiments, a remote device such as a display device is configured to generate a magnetic field which, when positioned in close proximity to the sensor electronics, latches a switch in the sensor electronics to drive the charge stored in the sensor electronics capacitor (generated from the self-powered sensor) to connect the remaining portions of the sensor electronics, effectively powering the sensor electronics solely from the charge stored in the capacitor that was generated by the self-powered sensor.


In a further embodiment, an on body sensor device including the self-powered sensor and sensor electronics is provided in a sealed housing and which does not include electronic components susceptible to sterilization processes for the sensor, and that would otherwise degrade or damage such electronic components. In this manner, in certain embodiments, a single enclosed housing including sensor electronics and the analyte sensor are provided which can be sterilized together using a single sterilization technique without damaging or degrading the components of the on body sensor device.


An analyte monitoring device in certain embodiments includes a self-powered analyte sensor having at least a portion in fluid contact with interstitial fluid under a skin surface, and sensor electronics operatively coupled to the self-powered analyte sensor, configured to receive signals generated by the self-powered analyte sensor, and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, the sensor electronics including: a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor, and a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level.


An analyte monitoring device in certain embodiments of the present disclosure includes a self-powered analyte sensor, and sensor electronics operatively coupled to the self-powered analyte sensor configured to receive signals generated by the self-powered analyte sensor and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, where the sensor electronics transitions from an inactive state to an active state when powered by a remote power source and upon receipt of a query signal from the remote power source, and in response to the query signal, communicates data corresponding to the generated signals associated with the monitored analyte level to the remote power source.


In certain embodiments, the self-powered analyte sensor is configured to continuously generate signals corresponding to monitored analyte level when in fluid contact with interstitial fluid.


In certain embodiments, the self-powered analyte sensor generates the signals corresponding to monitored analyte level when the sensor electronics are in the inactive state.


In certain embodiments, the sensor electronics are not operational when in the inactive state.


In certain embodiments, the sensor electronics include a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor.


In certain embodiments, the sensor electronics includes a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level.


In certain embodiments, the analyte monitoring device further includes a housing enclosing the self-powered sensor and the sensor electronics, wherein the housing is sealed to inhibit moisture from entering the housing.


In certain embodiments, the query signal includes an RFID signal.


In certain embodiments, the sensor electronics transition from the active state to the inactive state when the sensor electronics is not within the range of the remote power source.


In certain embodiments, the self-powered sensor is configured to generate the signals when in contact with the interstitial fluid and when the sensor electronics is in the inactive state.


In certain embodiments, the analyte monitoring device includes a housing enclosing the self-powered sensor and the sensor electronics, the housing including one or more mechanical components for physically detachably engaging with a remote device.


In certain embodiments, the remote device includes the remote power source.


In certain embodiments, the one or more mechanical components include one or more of a releasable latch, a releasable arm, or a releasable lock.


An analyte monitoring device, in certain embodiments, includes a self-powered analyte sensor having at least a portion in fluid contact with interstitial fluid under a skin surface, and sensor electronics operatively coupled to the self-powered analyte sensor configured to receive signals generated by the self-powered analyte sensor and to communicate data corresponding to analyte level monitored by the self-powered analyte sensor, the sensor electronics including: a buffering circuit operatively coupled to the self-powered analyte sensor for receiving the generated signals from the self-powered analyte sensor; and a radio frequency identification device (RFID) circuit operatively coupled to the buffering circuit and configured to communicate data corresponding to the generated signals associated with the monitored analyte level, where the sensor electronics transitions from an inactive state to an active state when powered by a remote power source and upon receipt of a query signal from the remote power source, and in response to the query signal, communicates data corresponding to the generated signals associated with the monitored analyte level to the remote power source.


In certain embodiments of the present disclosure, using the signals generated by the oxidation reaction of the self-powered sensor accumulated over time and stored in a capacitor device, sufficient charge is accumulated to drive the sensor electronics for processing signals related to the monitored analyte level, including storing, filtering, processing and communicating to a remote location. In this manner, sensor electronics coupled to the self-powered analyte sensor does not require a separate power source such as a battery to power the sensor electronics for processing signals related to the monitored analyte level including storing the generated and processed signals.


In some embodiments, a remote device such as a display device is configured to generate a magnetic field which, when positioned in close proximity to the sensor electronics, latches a switch in the sensor electronics to drive the charge stored in the sensor electronics capacitor device (generated from the self-powered sensor) to connect the remaining portions of the sensor electronics, effectively powering the sensor electronics solely from the charge stored in the capacitor that was generated by the self-powered sensor.


In a further embodiment, the self-powered sensor and sensor electronics are provided in a sealed housing and which does not include electronic components susceptible to sterilization processes for the sensor, and that would otherwise degrade or damage such electronic components. In this manner, in certain embodiments, a single enclosed housing including sensor electronics and the analyte sensor are provided which can be sterilized together using a single sterilization technique without damaging or degrading the components of the on body sensor device.


A method of monitoring analyte levels, in certain embodiments, includes transcutaneously positioning an analyte sensor in fluid contact with interstitial fluid under a skin surface, accumulating charge for a predetermined time period in a capacitor device in sensor electronics, the capacitor device in signal communication with the analyte sensor and receiving signals from the analyte sensor, detecting a magnetic field exceeding a threshold level, latching a switch provided in the sensor electronics to couple the capacitor device in the sensor electronics to sensor signal processing components when the detected magnetic field exceeds the threshold level, and connecting the capacitor device to the sensor signal processing components to provide power to the sensor signals processing components with the accumulated charge in the capacitor device.


A device for monitoring analyte level, in certain embodiments, includes an analyte sensor for transcutaneous positioning in fluid contact with interstitial fluid, sensor electronics including: sensor signal processing components, a capacitor device operatively coupled to the analyte sensor to accumulate charge for a predetermined time period, and a switch configured to latch, when a magnetic field exceeding a threshold level is detected, to couple the capacitor device to sensor signal processing components, where when the switch is latched, the capacitor device is configured to provide power to the sensor signals processing components with the accumulated charge in the capacitor device.


Various other modifications and alterations in the structure and method of operation of this disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the embodiments of the present disclosure. Although the present disclosure has been described in connection with particular embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such particular embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. A method of monitoring analyte levels, comprising: generating a current by an analyte sensor when in contact with interstitial fluid, the current corresponding to monitored analyte levels;receiving, by a capacitor device in sensor electronics, the current through a switch in the sensor electronics to accumulate charge in the capacitor device, wherein the switch is positioned between the analyte sensor and the capacitor device, wherein the switch has a first state and a second state, wherein the capacitor device receives the current generated by the analyte sensor when the switch is in the first state and wherein the capacitor device is unable to receive the current generated by the analyte sensor when the switch is in the second state;switching, by the switch, from the first state to the second state upon detecting a first magnetic field generated by a display device that exceeds a threshold level;discharging, by the capacitor device when the switch is in the second state, accumulated charge to power one or more sensor signal processing components in the sensor electronics, wherein a first component of the one or more sensor signal processing components comprises a wire loop configured to generate a magnetic pulse signal indicating that the switch is in the second state by using the accumulated charge discharged from the capacitor device.
  • 2. The method of claim 1, wherein the analyte sensor is a self-powered analyte sensor, and wherein the current generated by the analyte sensor is proportional to an analyte concentration in the interstitial fluid.
  • 3. The method of claim 1, further comprising: generating, by the display device, the first magnetic field; anddetermining, by the display device, that the switch is in the second state upon detecting the magnetic pulse signal.
  • 4. The method of claim 1, wherein a resistor is positioned between the analyte sensor and the switch for limiting the current received by the capacitor device from the analyte sensor.
  • 5. The method of claim 1, further comprising: determining one or more analyte values based on the generated current when the switch is in the second state, and storing the determined one or more analyte values when the switch is in the second state, thereby resulting in stored analyte values.
  • 6. The method of claim 1, further comprising: communicating one or more signals corresponding to the monitored analyte levels when the switch is in the second state from the sensor electronics to the display device.
  • 7. The method of claim 3, further comprising: displaying, by the display device, a number of times the switch has been switched to the second state based on the determination that the switch is in the second state upon detecting the magnetic pulse signal.
  • 8. The method of claim 1, further comprising: determining one or more analyte values based on the generated current when the switch is in the second state;storing the determined one or more analyte values when the switch is in the second state, thereby resulting in stored analyte values; andcommunicating one or more signals indicative of the stored analyte values when the switch is in the second state from the sensor electronics to the display device.
  • 9. The method of claim 1, further comprising: switching, by the switch, from the second state to the first state upon detecting that the first magnetic field is below the threshold level.
  • 10. A device for monitoring analyte levels, comprising: an analyte sensor configured to generate current when in contact with interstitial fluid, the current corresponding to monitored analyte levels; andsensor electronics comprising: a capacitor device, a switch positioned between the analyte sensor and the capacitor device, and one or more sensor signal processing components, wherein: the capacitor device is configured to receive the current through the switch to accumulate charge, wherein the switch has a first state and a second state, wherein the capacitor device is operably coupled to the analyte sensor when the switch is in the first state such that the capacitor device is able to receive the current, and wherein the capacitor device is operably decoupled from the analyte sensor when the switch is in the second state such that the capacitor device is unable to receive the current;the switch is configured to switch from the first state to the second state upon detecting a first magnetic field generated by a display device that exceeds a threshold level; andthe capacitor is configured to discharge, when the switch is in the second state, accumulated charge to power the one or more sensor signal processing components, wherein a first component of the one or more sensor signal processing components comprises a wire loop configured to generate a magnetic pulse signal indicating that the switch is in the second state by using the accumulated charge discharged from the capacitor device.
  • 11. The device of claim 10, wherein the analyte sensor is a self-powered analyte sensor, and wherein the current that the analyte sensor is configured to generate is proportional to an analyte concentration in the interstitial fluid.
  • 12. The device of claim 10, wherein the sensor electronics further comprise a resistor positioned between the analyte sensor and the switch for limiting current received by the capacitor device from the analyte sensor.
  • 13. The device of claim 10, wherein the sensor electronics are configured to determine one or more analyte values based on the generated current when the switch is in the second state and comprises a data storage unit configured to store the determined one or more analyte values when the switch is in the second state, thereby resulting in stored analyte values.
  • 14. The device of claim 10, wherein the sensor electronics are configured to determine one or more analyte values based on the generated current when the switch is in the second state, and further comprise: a data storage unit configured to store the determined one or more analyte values when the switch is in the second state, thereby resulting in stored analyte values, anda data communication unit configured to communicate one or more signals indicative of the stored analyte values when the switch is in the second state from the sensor electronics to the display device.
  • 15. The device of claim 10, wherein the switch is configured to switch from the second state to the first state upon detecting that the first magnetic field is below the threshold level.
RELATED APPLICATION

The present application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 61/922,404 filed Dec. 31, 2013, entitled “Self-Powered Analyte Sensor and Devices Using the Same,” the disclosure of which is incorporated herein by reference for all purposes.

US Referenced Citations (1014)
Number Name Date Kind
3164534 Free Jan 1965 A
3581062 Aston May 1971 A
3926760 Allen et al. Dec 1975 A
3949388 Fuller Apr 1976 A
3960497 Acord et al. Jun 1976 A
4036749 Anderson Jul 1977 A
4055175 Clemens et al. Oct 1977 A
4129128 McFarlane Dec 1978 A
4245634 Albisser et al. Jan 1981 A
4327725 Cortese et al. May 1982 A
4344438 Schultz Aug 1982 A
4349728 Phillips et al. Sep 1982 A
4373527 Fischell Feb 1983 A
4392849 Petre et al. Jul 1983 A
4425920 Bourland et al. Jan 1984 A
4431004 Bessman et al. Feb 1984 A
4441968 Emmer et al. Apr 1984 A
4478976 Goertz et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4509531 Ward Apr 1985 A
4527240 Kvitash Jul 1985 A
4538616 Rogoff Sep 1985 A
4545382 Higgins et al. Oct 1985 A
4550076 Chikazawa et al. Oct 1985 A
4619793 Lee Oct 1986 A
4627445 Garcia et al. Dec 1986 A
4671288 Gough Jun 1987 A
4703756 Gough et al. Nov 1987 A
4711245 Higgins et al. Dec 1987 A
4731726 Allen, III Mar 1988 A
4749985 Corsberg Jun 1988 A
4757022 Shults et al. Jul 1988 A
4777953 Ash et al. Oct 1988 A
4779618 Mund et al. Oct 1988 A
4820399 Senda et al. Apr 1989 A
4854322 Ash et al. Aug 1989 A
4871351 Feingold Oct 1989 A
4890620 Gough Jan 1990 A
4891104 Liston et al. Jan 1990 A
4897162 Lewandowski et al. Jan 1990 A
4925268 Iyer et al. May 1990 A
4953552 DeMarzo Sep 1990 A
4974929 Curry Dec 1990 A
4986271 Wilkins Jan 1991 A
4995402 Smith et al. Feb 1991 A
5000180 Kuypers et al. Mar 1991 A
5002054 Ash et al. Mar 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5055171 Peck Oct 1991 A
5068536 Rosenthal Nov 1991 A
5077476 Rosenthal Dec 1991 A
5082550 Rishpon et al. Jan 1992 A
5106365 Hernandez Apr 1992 A
5122925 Inpyn Jun 1992 A
5165407 Wilson et al. Nov 1992 A
5200051 Cozzette et al. Apr 1993 A
5202261 Musho et al. Apr 1993 A
5202317 Bruice Apr 1993 A
5204264 Kaminer et al. Apr 1993 A
5210778 Massart May 1993 A
5217966 Bruice Jun 1993 A
5227405 Friedovich et al. Jul 1993 A
5246867 Lakowicz et al. Sep 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279294 Anderson et al. Jan 1994 A
5285792 Sjoquist et al. Feb 1994 A
5293877 O'Hara et al. Mar 1994 A
5299571 Mastrototaro Apr 1994 A
5320715 Berg Jun 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5330634 Wong et al. Jul 1994 A
5340722 Wolfbeis et al. Aug 1994 A
5342789 Chick et al. Aug 1994 A
5356786 Heller et al. Oct 1994 A
5360404 Novacek et al. Nov 1994 A
5372427 Padovani et al. Dec 1994 A
5379238 Stark Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5408999 Singh et al. Apr 1995 A
5411647 Johnson et al. May 1995 A
5425868 Pedersen Jun 1995 A
5431160 Wilkins Jul 1995 A
5431921 Thombre Jul 1995 A
5438983 Falcone Aug 1995 A
5462645 Albery et al. Oct 1995 A
5466575 Cozzette et al. Nov 1995 A
5468562 Farivar et al. Nov 1995 A
5472317 Field et al. Dec 1995 A
5489414 Schreiber et al. Feb 1996 A
5497772 Schulman et al. Mar 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5509410 Hill et al. Apr 1996 A
5514718 Lewis et al. May 1996 A
5531878 Vadgama et al. Jul 1996 A
5543326 Heller et al. Aug 1996 A
5552997 Massart Sep 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5601435 Quy Feb 1997 A
5609575 Larson et al. Mar 1997 A
5610293 Riley et al. Mar 1997 A
5628310 Rao et al. May 1997 A
5628890 Nigel et al. May 1997 A
5640954 Pfeiffer et al. Jun 1997 A
5651869 Yoshioka et al. Jul 1997 A
5653239 Pompei et al. Aug 1997 A
5665222 Heller et al. Sep 1997 A
5696109 Malfroy-Camine et al. Dec 1997 A
5711001 Bussan et al. Jan 1998 A
5711861 Ward et al. Jan 1998 A
5733259 Valcke et al. Mar 1998 A
5735285 Albert et al. Apr 1998 A
5771890 Tamada Jun 1998 A
5772586 Heinonen et al. Jun 1998 A
5791344 Schulman et al. Aug 1998 A
5807375 Gross et al. Sep 1998 A
5814020 Gross Sep 1998 A
5820551 Hill et al. Oct 1998 A
5820570 Erickson et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5858001 Tsais et al. Jan 1999 A
5882494 Van Antwerp Mar 1999 A
5899855 Brown May 1999 A
5906921 Ikeda et al. May 1999 A
5914026 Blubaugh et al. Jun 1999 A
5918603 Brown Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5931868 Gross et al. Aug 1999 A
5935224 Svancarek et al. Aug 1999 A
5942979 Luppino Aug 1999 A
5947957 Morris Sep 1999 A
5957854 Besson et al. Sep 1999 A
5961451 Reber et al. Oct 1999 A
5964993 Blubaugh, Jr. et al. Oct 1999 A
5965380 Heller et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
5972199 Heller et al. Oct 1999 A
5993411 Choi Nov 1999 A
5994339 Crapo et al. Nov 1999 A
5995860 Sun et al. Nov 1999 A
5997501 Gross et al. Dec 1999 A
6001067 Shults et al. Dec 1999 A
6011077 Muller Jan 2000 A
6023629 Tamada Feb 2000 A
6024699 Surwit et al. Feb 2000 A
6049727 Crothall Apr 2000 A
6071391 Gotoh et al. Jun 2000 A
6081736 Colvin et al. Jun 2000 A
6083710 Heller et al. Jul 2000 A
6084093 Riley et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6091976 Pfeiffer et al. Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6103033 Say et al. Aug 2000 A
6103714 Fridovich et al. Aug 2000 A
6110155 Baudino Aug 2000 A
6117290 Say et al. Sep 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6121611 Lindsay et al. Sep 2000 A
6122351 Schlueter, Jr. et al. Sep 2000 A
6122536 Sun et al. Sep 2000 A
6127356 Crapo et al. Oct 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6144837 Quy Nov 2000 A
6144869 Berner et al. Nov 2000 A
6159147 Lichter et al. Dec 2000 A
6161095 Brown Dec 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6186982 Gross et al. Feb 2001 B1
6190315 Kost et al. Feb 2001 B1
6200265 Walsh et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6214817 Riley et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6233471 Berner et al. May 2001 B1
6240306 Rohrscheib et al. May 2001 B1
6245758 Stem et al. Jun 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6267002 Ehwald et al. Jul 2001 B1
6268161 Han et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6275717 Gross et al. Aug 2001 B1
6283761 Joao Sep 2001 B1
6284478 Heller et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6298254 Tamada Oct 2001 B2
6299347 Pompei Oct 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309884 Cooper et al. Oct 2001 B1
6329161 Heller et al. Dec 2001 B1
6331244 Lewis et al. Dec 2001 B1
6338790 Feldman et al. Jan 2002 B1
6343225 Clark, Jr. Jan 2002 B1
6348640 Navot et al. Feb 2002 B1
6359444 Grimes Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6366794 Moussy et al. Apr 2002 B1
6368141 Van Antwerp et al. Apr 2002 B1
6368274 Van Antwerp et al. Apr 2002 B1
6372045 McCabe et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6377894 Deweese et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6387048 Schulman et al. May 2002 B1
6400974 Lesho Jun 2002 B1
6403788 Meunier et al. Jun 2002 B1
6405066 Essenpreis et al. Jun 2002 B1
6413393 Van Antwerp et al. Jul 2002 B1
6418332 Mastrototaro et al. Jul 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6434409 Pfeiffer et al. Aug 2002 B1
6436255 Yamamoto et al. Aug 2002 B2
6438414 Conn et al. Aug 2002 B1
6440068 Brown et al. Aug 2002 B1
6445374 Albert et al. Sep 2002 B2
6448239 Groves et al. Sep 2002 B1
6461496 Feldman et al. Oct 2002 B1
6466810 Ward et al. Oct 2002 B1
6471689 Joseph et al. Oct 2002 B1
6475181 Potter et al. Nov 2002 B1
6475196 Vachon Nov 2002 B1
6477395 Schulman et al. Nov 2002 B2
6477891 Ehwald et al. Nov 2002 B2
6478736 Mault Nov 2002 B1
6479477 Crapo et al. Nov 2002 B1
6482176 Wich Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6491657 Rowe et al. Dec 2002 B2
6493069 Nagashimada et al. Dec 2002 B1
6497729 Moussy et al. Dec 2002 B1
6503381 Gotoh et al. Jan 2003 B1
6508785 Eppstein Jan 2003 B1
6512939 Colvin et al. Jan 2003 B1
6514460 Fendrock Feb 2003 B1
6514718 Heller et al. Feb 2003 B2
6520326 Mclvor et al. Feb 2003 B2
6525041 Neumann et al. Feb 2003 B1
6530915 Eppstein et al. Mar 2003 B1
6540891 Stewart et al. Apr 2003 B1
6541490 Campbell et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6544975 Crapo et al. Apr 2003 B1
6546268 Ishikawa et al. Apr 2003 B1
6551494 Heller et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6565509 Say et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6573257 Malfroy-Camine et al. Jun 2003 B2
6574490 Abbink et al. Jun 2003 B2
6576101 Heller et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579690 Bonnecaze et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6589948 Malfroy-Camine et al. Jul 2003 B1
6591125 Buse et al. Jul 2003 B1
6591126 Roeper et al. Jul 2003 B2
6592745 Feldman et al. Jul 2003 B1
6592746 Schmid-Schoenbein et al. Jul 2003 B1
6595919 Berner et al. Jul 2003 B2
6599407 Taniike et al. Jul 2003 B2
6600997 Deweese et al. Jul 2003 B2
6602678 Kwon et al. Aug 2003 B2
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6616819 Liamos et al. Sep 2003 B1
6618934 Feldman et al. Sep 2003 B1
6620123 Mitragotri et al. Sep 2003 B1
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6648821 Lebel et al. Nov 2003 B2
6650471 Doi Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6656114 Poulson et al. Dec 2003 B1
6658396 Tang et al. Dec 2003 B1
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6676816 Mao et al. Jan 2004 B2
6679841 Bojan et al. Jan 2004 B2
6685699 Eppstein et al. Feb 2004 B1
6687546 Lebel et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6694191 Starkweather et al. Feb 2004 B2
6695860 Ward et al. Feb 2004 B1
6698269 Baber et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6706049 Moerman Mar 2004 B2
6723077 Pickup et al. Apr 2004 B2
6730200 Stewart et al. May 2004 B1
6733446 Lebel et al. May 2004 B2
6736957 Forrow et al. May 2004 B1
6740075 Lebel et al. May 2004 B2
6740215 Nakaminami et al. May 2004 B1
6741877 Shults et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6749740 Liamos et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6764581 Forrow et al. Jul 2004 B1
6770030 Schaupp et al. Aug 2004 B1
6770729 Van Antwerp Aug 2004 B2
6773671 Lewis et al. Aug 2004 B1
6790178 Mault et al. Sep 2004 B1
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6835387 Herrmann Dec 2004 B2
6837988 Leong et al. Jan 2005 B2
6850790 Berner et al. Feb 2005 B2
6862465 Shults et al. Mar 2005 B2
6865407 Kimball et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6881551 Heller et al. Apr 2005 B2
6885196 Taniike et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893545 Gotoh et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6895265 Silver May 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6931327 Goode, Jr. et al. Aug 2005 B2
6932892 Chen et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6936006 Sabra Aug 2005 B2
6942518 Liamos et al. Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6968294 Gutta et al. Nov 2005 B2
6971274 Olin Dec 2005 B2
6971999 Py et al. Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6990366 Say et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
7003336 Holker et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7016713 Gardner et al. Mar 2006 B2
7022072 Fox et al. Apr 2006 B2
7022219 Mansouri et al. Apr 2006 B2
7024245 Lebel et al. Apr 2006 B2
7027931 Jones et al. Apr 2006 B1
7029444 Shin et al. Apr 2006 B2
7041068 Freeman et al. May 2006 B2
7041468 Drucker et al. May 2006 B2
7052483 Wojcik May 2006 B2
7056302 Douglas Jun 2006 B2
7074307 Simpson et al. Jul 2006 B2
7081195 Simpson et al. Jul 2006 B2
7092891 Maus et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7113821 Sun et al. Sep 2006 B1
7118667 Lee Oct 2006 B2
7123950 Mannheimer Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7153265 Vachon Dec 2006 B2
7167818 Brown Jan 2007 B2
7171274 Starkweather et al. Jan 2007 B2
7190988 Say et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198606 Boecker et al. Apr 2007 B2
7225535 Feldman et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7258673 Racchini et al. Aug 2007 B2
7267665 Steil et al. Sep 2007 B2
7276029 Goode et al. Oct 2007 B2
7278983 Ireland et al. Oct 2007 B2
7295867 Berner et al. Nov 2007 B2
7299082 Feldman et al. Nov 2007 B2
7310544 Brister et al. Dec 2007 B2
7335294 Heller et al. Feb 2008 B2
7354420 Steil et al. Apr 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7379765 Petisce et al. May 2008 B2
7381184 Funderburk et al. Jun 2008 B2
7387010 Sunshine Jun 2008 B2
7402153 Steil et al. Jul 2008 B2
7404796 Ginsberg Jul 2008 B2
7424318 Brister et al. Sep 2008 B2
7460898 Brister et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7509153 Blank et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7547281 Hayes et al. Jun 2009 B2
7569030 Lebel et al. Aug 2009 B2
7583990 Goode et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode et al. Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7618369 Hayter et al. Nov 2009 B2
7630748 Budiman Dec 2009 B2
7632228 Brauker et al. Dec 2009 B2
7635594 Holmes et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbies et al. Dec 2009 B2
7651596 Petisce et al. Jan 2010 B2
7653425 Hayter et al. Jan 2010 B2
7654956 Brister et al. Feb 2010 B2
7657297 Simpson et al. Feb 2010 B2
7697967 Stafford Apr 2010 B2
7699775 Desai et al. Apr 2010 B2
7699964 Feldman et al. Apr 2010 B2
7711402 Shults et al. May 2010 B2
7713574 Brister et al. May 2010 B2
7715893 Kamath et al. May 2010 B2
7736310 Taub et al. Jun 2010 B2
7766829 Sloan et al. Aug 2010 B2
7771352 Shults et al. Aug 2010 B2
7774145 Bruaker et al. Aug 2010 B2
7778680 Goode, Jr. et al. Aug 2010 B2
7778795 Fukushima et al. Aug 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7866026 Wang et al. Jan 2011 B1
7882611 Shah et al. Feb 2011 B2
7889069 Fifolt et al. Feb 2011 B2
7899511 Shults et al. Mar 2011 B2
7905833 Brister et al. Mar 2011 B2
7911010 Stetter Mar 2011 B2
7914450 Goode, Jr. et al. Mar 2011 B2
7938797 Estes May 2011 B2
7954385 Raisanen Jun 2011 B2
7974672 Shults et al. Jul 2011 B2
8216138 McGarraugh et al. Jul 2012 B1
8282549 Brauker et al. Oct 2012 B2
20010020125 Kurnik et al. Sep 2001 A1
20010039393 Mori et al. Nov 2001 A1
20010041830 Varalli et al. Nov 2001 A1
20020006634 Han et al. Jan 2002 A1
20020019022 Dunn et al. Feb 2002 A1
20020023852 McIvor et al. Feb 2002 A1
20020026110 Parris et al. Feb 2002 A1
20020042090 Heller et al. Apr 2002 A1
20020042407 Fridovich et al. Apr 2002 A1
20020055711 Lavi et al. May 2002 A1
20020068860 Clark Jun 2002 A1
20020082490 Roeper et al. Jun 2002 A1
20020082543 Park et al. Jun 2002 A1
20020103499 Perez et al. Aug 2002 A1
20020106709 Potts et al. Aug 2002 A1
20020128594 Das et al. Sep 2002 A1
20020161288 Shin et al. Oct 2002 A1
20020168290 Yuzhakov et al. Nov 2002 A1
20020169635 Shillingburg Nov 2002 A1
20020183604 Gowda et al. Dec 2002 A1
20030004403 Drinan et al. Jan 2003 A1
20030023317 Brauker et al. Jan 2003 A1
20030023461 Quintanilla et al. Jan 2003 A1
20030031699 Van Antwerp Feb 2003 A1
20030032867 Crothall et al. Feb 2003 A1
20030032874 Rhodes et al. Feb 2003 A1
20030004213 Mao et al. Mar 2003 A1
20030045798 Hular et al. Mar 2003 A1
20030055032 Groves et al. Mar 2003 A1
20030060692 Ruchti et al. Mar 2003 A1
20030065254 Schulman et al. Apr 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030069281 Fridovich et al. Apr 2003 A1
20030077702 Shah et al. Apr 2003 A1
20030077772 Shah et al. Apr 2003 A1
20030078560 Miller et al. Apr 2003 A1
20030099682 Moussy et al. May 2003 A1
20030100821 Heller et al. May 2003 A1
20030118577 Weill et al. Jun 2003 A1
20030125612 Fox et al. Jul 2003 A1
20030130616 Steil et al. Jul 2003 A1
20030134347 Heller et al. Jul 2003 A1
20030168338 Gao et al. Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030187338 Say et al. Oct 2003 A1
20030190341 Shalaby et al. Oct 2003 A1
20030191377 Robinson et al. Oct 2003 A1
20030199744 Buse et al. Oct 2003 A1
20030199790 Boecker et al. Oct 2003 A1
20030199837 Vachon Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030212317 Kovatchev et al. Nov 2003 A1
20030212346 Yuzhakov et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216630 Jersey-Willuhn et al. Nov 2003 A1
20030217966 Tapsak et al. Nov 2003 A1
20040010186 Kimball et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040011671 Shults et al. Jan 2004 A1
20040024553 Monfre et al. Feb 2004 A1
20040028612 Singaram et al. Feb 2004 A1
20040039298 Abreu Feb 2004 A1
20040040840 Mao et al. Mar 2004 A1
20040045879 Shults et al. Mar 2004 A1
20040054263 Moerman et al. Mar 2004 A1
20040063167 Kaastrup et al. Apr 2004 A1
20040064068 DeNuzzio et al. Apr 2004 A1
20040064133 Miller et al. Apr 2004 A1
20040074785 Holker et al. Apr 2004 A1
20040096959 Steine et al. May 2004 A1
20040099529 Mao et al. May 2004 A1
20040106858 Say et al. Jun 2004 A1
20040110722 Qmberg et al. Jun 2004 A1
20040116332 Qmberg et al. Jun 2004 A1
20040116847 Wall Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040116866 Gorman et al. Jul 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040135684 Steinthal et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040146909 Duong et al. Jul 2004 A1
20040147996 Miazga et al. Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040172307 Gruber Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040186362 Brauker et al. Sep 2004 A1
20040186365 Jin et al. Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193090 Lebel et al. Sep 2004 A1
20040197846 Hockersmith et al. Oct 2004 A1
20040199059 Brauker et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204868 Maynard et al. Oct 2004 A1
20040223985 Dunfiled et al. Nov 2004 A1
20040225338 Lebel et al. Nov 2004 A1
20040236200 Say et al. Nov 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040249254 Racchini et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040260478 Schwamm Dec 2004 A1
20040263354 Mann et al. Dec 2004 A1
20040267300 Mace Dec 2004 A1
20050004439 Shin et al. Jan 2005 A1
20050004494 Perez et al. Jan 2005 A1
20050010269 Lebel et al. Jan 2005 A1
20050027177 Shin et al. Feb 2005 A1
20050027180 Goode et al. Feb 2005 A1
20050027181 Goode et al. Feb 2005 A1
20050027462 Goode et al. Feb 2005 A1
20050027463 Goode et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050033132 Shults et al. Feb 2005 A1
20050038332 Saidara et al. Feb 2005 A1
20050043598 Goode, Jr. et al. Feb 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050054908 Blank et al. Mar 2005 A1
20050054909 Petisce et al. Mar 2005 A1
20050070774 Addison et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050096511 Fox et al. May 2005 A1
20050096512 Fox et al. May 2005 A1
20050096520 Maekawa et al. May 2005 A1
20050112169 Brauker et al. May 2005 A1
20050113653 Fox et al. May 2005 A1
20050114068 Chey et al. May 2005 A1
20050121322 Say et al. Jun 2005 A1
20050131346 Douglas Jun 2005 A1
20050143635 Kamath et al. Jun 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050173245 Feldman et al. Aug 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050177398 Watanabe et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050187720 Goode, Jr. et al. Aug 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050199494 Say et al. Sep 2005 A1
20050203360 Brauker et al. Sep 2005 A1
20050214892 Kovatchev et al. Sep 2005 A1
20050215871 Feldman et al. Sep 2005 A1
20050239154 Feldman et al. Oct 2005 A1
20050239156 Drucker et al. Oct 2005 A1
20050241957 Mao et al. Nov 2005 A1
20050245795 Goode, Jr. et al. Nov 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050245839 Stivoric et al. Nov 2005 A1
20050245904 Estes et al. Nov 2005 A1
20050277164 Drucker et al. Dec 2005 A1
20050277912 John Dec 2005 A1
20050287620 Heller et al. Dec 2005 A1
20060001538 Kraft et al. Jan 2006 A1
20060004270 Bedard et al. Jan 2006 A1
20060010098 Goodnow et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060016700 Brister et al. Jan 2006 A1
20060017923 Ruchti et al. Jan 2006 A1
20060019327 Brister et al. Jan 2006 A1
20060020186 Brister et al. Jan 2006 A1
20060020187 Brister et al. Jan 2006 A1
20060020188 Kamath et al. Jan 2006 A1
20060020189 Brister et al. Jan 2006 A1
20060020190 Kamath et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060020192 Brister et al. Jan 2006 A1
20060020300 Nghiem et al. Jan 2006 A1
20060025662 Buse et al. Feb 2006 A1
20060029177 Cranford, Jr. et al. Feb 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060036139 Brister et al. Feb 2006 A1
20060036140 Brister et al. Feb 2006 A1
20060036141 Kamath et al. Feb 2006 A1
20060036142 Brister et al. Feb 2006 A1
20060036143 Brister et al. Feb 2006 A1
20060036144 Brister et al. Feb 2006 A1
20060036145 Brister Feb 2006 A1
20060091006 Wang et al. May 2006 A1
20060142651 Brister et al. Jun 2006 A1
20060155180 Brister et al. Jul 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060170535 Watters et al. Aug 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173444 Choy et al. Aug 2006 A1
20060183984 Dobbies et al. Aug 2006 A1
20060183985 Brister et al. Aug 2006 A1
20060189863 Peyser et al. Aug 2006 A1
20060193375 Lee Aug 2006 A1
20060219576 Jina et al. Oct 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224109 Steil et al. Oct 2006 A1
20060226985 Goodnow et al. Oct 2006 A1
20060229512 Petisce et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060247985 Liamos et al. Nov 2006 A1
20060258929 Goode et al. Nov 2006 A1
20060272652 Stocker et al. Dec 2006 A1
20060281985 Ward et al. Dec 2006 A1
20070000163 Kamath et al. Jan 2007 A1
20070000273 Stafford Feb 2007 A1
20070032717 Brister et al. Feb 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070056858 Chen et al. Mar 2007 A1
20070060803 Liljeryd et al. Mar 2007 A1
20070060814 Stafford Mar 2007 A1
20070066873 Kamath et al. Mar 2007 A1
20070068807 Feldman et al. Mar 2007 A1
20070071681 Gadkar et al. Mar 2007 A1
20070073129 Shah et al. Mar 2007 A1
20070078320 Stafford Apr 2007 A1
20070078321 Mazza et al. Apr 2007 A1
20070078322 Stafford Apr 2007 A1
20070078323 Reggiardo et al. Apr 2007 A1
20070095661 Wang et al. May 2007 A1
20070106135 Sloan et al. May 2007 A1
20070106175 Uchiyama May 2007 A1
20070108048 Wang et al. May 2007 A1
20070124002 Estes et al. May 2007 A1
20070129602 Bettesh et al. Jun 2007 A1
20070149875 Quyang et al. Jun 2007 A1
20070156033 Causey, III et al. Jul 2007 A1
20070163880 Woo et al. Jul 2007 A1
20070163894 Wang et al. Jul 2007 A1
20070168224 Letzt et al. Jul 2007 A1
20070173706 Neinast et al. Jul 2007 A1
20070173709 Petisce et al. Jul 2007 A1
20070173710 Petisce et al. Jul 2007 A1
20070173761 Kanderian et al. Jul 2007 A1
20070179349 Hoyme et al. Aug 2007 A1
20070179352 Randlov et al. Aug 2007 A1
20070179434 Weinert et al. Aug 2007 A1
20070191701 Feldman et al. Aug 2007 A1
20070197957 Hunter et al. Aug 2007 A1
20070199818 Petyt et al. Aug 2007 A1
20070203407 Hoss et al. Aug 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070219496 Kamen et al. Sep 2007 A1
20070227911 Wang et al. Oct 2007 A1
20070232878 Kovatchev et al. Oct 2007 A1
20070232880 Siddiqui et al. Oct 2007 A1
20070233013 Schoenberg et al. Oct 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20070249922 Peyser et al. Oct 2007 A1
20070255321 Gerber et al. Nov 2007 A1
20070258395 Jollota et al. Nov 2007 A1
20070282299 Hellwig Dec 2007 A1
20070299617 Willis Dec 2007 A1
20080004515 Jennewine et al. Jan 2008 A1
20080004601 Jennewine et al. Jan 2008 A1
20080009692 Stafford Jan 2008 A1
20080017522 Heller et al. Jan 2008 A1
20080021666 Goode, Jr. et al. Jan 2008 A1
20080029391 Mao et al. Feb 2008 A1
20080030369 Mann et al. Feb 2008 A1
20080033254 Kamath et al. Feb 2008 A1
20080033268 Stafford Feb 2008 A1
20080039702 Hayter et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080058625 McGarraugh et al. Mar 2008 A1
20080064937 McGarraugh et al. Mar 2008 A1
20080066305 Wang et al. Mar 2008 A1
20080071156 Brister et al. Mar 2008 A1
20080071157 McGarraugh et al. Mar 2008 A1
20080071158 McGarraugh et al. Mar 2008 A1
20080081977 Hayter et al. Apr 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080086042 Brister et al. Apr 2008 A1
20080086044 Brister et al. Apr 2008 A1
20080086273 Shults et al. Apr 2008 A1
20080097246 Stafford Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080102441 Chen et al. May 2008 A1
20080108942 Brister et al. May 2008 A1
20080114280 Stafford May 2008 A1
20080119703 Brister et al. May 2008 A1
20080119707 Stafford May 2008 A1
20080119708 Budiman May 2008 A1
20080129486 Jeckelmann Jun 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080148873 Wang Jun 2008 A1
20080154513 Kovatchev et al. Jun 2008 A1
20080161666 Feldman et al. Jul 2008 A1
20080167543 Say et al. Jul 2008 A1
20080172205 Breton et al. Jul 2008 A1
20080177149 Weinert et al. Jul 2008 A1
20080183060 Steil et al. Jul 2008 A1
20080183061 Goode et al. Jul 2008 A1
20080183399 Goode et al. Jul 2008 A1
20080019493 Brister et al. Aug 2008 A1
20080188731 Brister et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080189051 Goode et al. Aug 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080194935 Brister et al. Aug 2008 A1
20080194936 Goode et al. Aug 2008 A1
20080194937 Goode et al. Aug 2008 A1
20080195049 Thalmann et al. Aug 2008 A1
20080195232 Carr-Brendel et al. Aug 2008 A1
20080195967 Goode et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080200897 Hoss et al. Aug 2008 A1
20080201325 Doniger et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080208113 Damiano et al. Aug 2008 A1
20080314395 Kovatchev et al. Aug 2008 A1
20080214915 Brister et al. Sep 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080234943 Ray et al. Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080242963 Essenpreis et al. Oct 2008 A1
20080255434 Hayter et al. Oct 2008 A1
20080255437 Hayter Oct 2008 A1
20080255808 Hayter Oct 2008 A1
20080256048 Hayter Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080267823 Wang et al. Oct 2008 A1
20080275313 Brister et al. Nov 2008 A1
20080287761 Hayter Nov 2008 A1
20080287762 Hayter Nov 2008 A1
20080287763 Hayter Nov 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080287765 Rasdal et al. Nov 2008 A1
20080287766 Rasdal et al. Nov 2008 A1
20080288180 Hayter Nov 2008 A1
20080288204 Hayter et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080300476 Stafford Dec 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20080306368 Goode et al. Dec 2008 A1
20080306434 Dobbies et al. Dec 2008 A1
20080306435 Kamath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20080312841 Hayter Dec 2008 A1
20080312842 Hayter Dec 2008 A1
20080312844 Hayter et al. Dec 2008 A1
20080312845 Hayter et al. Dec 2008 A1
20090005665 Hayter et al. Jan 2009 A1
20090005666 Shin et al. Jan 2009 A1
20090006034 Hayter et al. Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006133 Weinert et al. Jan 2009 A1
20090012377 Jennewine et al. Jan 2009 A1
20090012379 Goode et al. Jan 2009 A1
20090018424 Kamath et al. Jan 2009 A1
20090018425 Quyang et al. Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090033482 Hayter et al. Feb 2009 A1
20090036747 Hayter et al. Feb 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036760 Hayter Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090043182 Brauker et al. Feb 2009 A1
20090043525 Brauker et al. Feb 2009 A1
20090043541 Brauker et al. Feb 2009 A1
20090043542 Brauker et al. Feb 2009 A1
20090045055 Rhodes et al. Feb 2009 A1
20090048503 Dalal et al. Feb 2009 A1
20090054745 Jennewine et al. Feb 2009 A1
20090054748 Feldman et al. Feb 2009 A1
20090055149 Hayter et al. Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090062635 Brauker et al. Mar 2009 A1
20090062767 VanAntwerp et al. Mar 2009 A1
20090063402 Hayter Mar 2009 A1
20090069750 Schraga Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076359 Peyser Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076361 Kamath et al. Mar 2009 A1
20090082693 Stafford Mar 2009 A1
20090085768 Patel et al. Apr 2009 A1
20090088614 Taub Apr 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090105560 Solomon Apr 2009 A1
20090105569 Stafford Apr 2009 A1
20090105570 Sloan et al. Apr 2009 A1
20090105571 Fennell et al. Apr 2009 A1
20090105636 Hayter et al. Apr 2009 A1
20090112478 Mueller, Jr. et al. Apr 2009 A1
20090124877 Goode et al. May 2009 A1
20090124878 Goode et al. May 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090131860 Nielsen May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090143660 Brister et al. Jun 2009 A1
20090156919 Brister et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163790 Brister et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090164190 Hayter Jun 2009 A1
20090164239 Hayter et al. Jun 2009 A1
20090164251 Hayter Jun 2009 A1
20090171182 Stafford Jul 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192380 Shariati et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Kamath et al. Jul 2009 A1
20090192751 Kamath et al. Jul 2009 A1
20090198118 Hayter et al. Aug 2009 A1
20090203981 Brauker et al. Aug 2009 A1
20090204341 Brauker et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090242399 Kamath et al. Oct 2009 A1
20090242425 Kamath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259118 Feldman et al. Oct 2009 A1
20090287073 Boock et al. Nov 2009 A1
20090287074 Shults et al. Nov 2009 A1
20090294277 Thomas et al. Dec 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20100010324 Brauker et al. Jan 2010 A1
20100010331 Brauker et al. Jan 2010 A1
20100010332 Brauker et al. Jan 2010 A1
20100016687 Brauker et al. Jan 2010 A1
20100016698 Rasdal et al. Jan 2010 A1
20100022855 Brauker et al. Jan 2010 A1
20100030038 Brauker et al. Feb 2010 A1
20100030053 Goode, Jr. et al. Feb 2010 A1
20100030484 Brauker et al. Feb 2010 A1
20100030485 Brauker et al. Feb 2010 A1
20100036215 Goode, Jr. et al. Feb 2010 A1
20100036216 Goode, Jr. et al. Feb 2010 A1
20100036222 Goode, Jr. et al. Feb 2010 A1
20100036223 Goode, Jr. et al. Feb 2010 A1
20100036225 Goode, Jr. et al. Feb 2010 A1
20100041971 Goode, Jr. et al. Feb 2010 A1
20100045465 Brauker et al. Feb 2010 A1
20100049024 Saint et al. Feb 2010 A1
20100057040 Hayter Mar 2010 A1
20100057041 Hayter Mar 2010 A1
20100057042 Hayter Mar 2010 A1
20100057044 Hayter Mar 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100063373 Kamath et al. Mar 2010 A1
20100076283 Simpson et al. Mar 2010 A1
20100081906 Hayter et al. Apr 2010 A1
20100081908 Dobbies et al. Apr 2010 A1
20100081909 Budiman et al. Apr 2010 A1
20100081910 Brister et al. Apr 2010 A1
20100087724 Brauker et al. Apr 2010 A1
20100096259 Zhang et al. Apr 2010 A1
20100099970 Shults et al. Apr 2010 A1
20100099971 Shults et al. Apr 2010 A1
20100119693 Tapsak et al. May 2010 A1
20100121167 McGarraugh et al. May 2010 A1
20100121169 Petisce et al. May 2010 A1
20100141656 Krieftewirth Jun 2010 A1
20100160759 Celentano et al. Jun 2010 A1
20100168538 Keenan et al. Jul 2010 A1
20100168546 Kamath et al. Jul 2010 A1
20100174266 Estes Jul 2010 A1
20100191085 Budiman Jul 2010 A1
20100191472 Doniger et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198142 Sloan et al. Aug 2010 A1
20100204557 Kiaie et al. Aug 2010 A1
20100213057 Feldman et al. Aug 2010 A1
20100230285 Hoss et al. Sep 2010 A1
20100234710 Budiman et al. Sep 2010 A1
20100265073 Harper et al. Oct 2010 A1
20100274515 Hoss et al. Oct 2010 A1
20100277119 Montague et al. Nov 2010 A1
20100277342 Sicurello et al. Nov 2010 A1
20100280441 Willinska et al. Nov 2010 A1
20100280782 Harper et al. Nov 2010 A1
20100312176 Lauer et al. Dec 2010 A1
20100312314 Ice et al. Dec 2010 A1
20100313105 Nekoomaram et al. Dec 2010 A1
20100317952 Budiman et al. Dec 2010 A1
20100324392 Yee et al. Dec 2010 A1
20100324853 Wang et al. Dec 2010 A1
20100326842 Mazza et al. Dec 2010 A1
20100331646 Hoss et al. Dec 2010 A1
20100331653 Stafford Dec 2010 A1
20110021889 Hoss et al. Jan 2011 A1
20110184258 Stafford Jan 2011 A1
20110024043 Boock et al. Feb 2011 A1
20110024307 Simpson et al. Feb 2011 A1
20110027127 Simpson et al. Feb 2011 A1
20110027453 Boock et al. Feb 2011 A1
20110027458 Boock et al. Feb 2011 A1
20110028815 Simpson et al. Feb 2011 A1
20110028816 Simpson et al. Feb 2011 A1
20110054275 Stafford Mar 2011 A1
20110060196 Stafford Mar 2011 A1
20110073475 Kastanos et al. Mar 2011 A1
20110077490 Simpson et al. Mar 2011 A1
20110077494 Doniger et al. Mar 2011 A1
20110081726 Berman et al. Apr 2011 A1
20110082484 Saravia et al. Apr 2011 A1
20110105873 Feldman et al. May 2011 A1
20110106126 Love et al. May 2011 A1
20110144463 Pesach et al. Jun 2011 A1
20110148905 Simmons et al. Jun 2011 A1
20110152637 Kateraas et al. Jun 2011 A1
20110160553 Talbot et al. Jun 2011 A1
20110319733 Stafford Jun 2011 A1
20110184268 Taub Jul 2011 A1
20110190603 Stafford Aug 2011 A1
20110191044 Stafford Aug 2011 A1
20110193704 Harper et al. Aug 2011 A1
20110208027 Wagner et al. Aug 2011 A1
20110208155 Palerm et al. Aug 2011 A1
20110213225 Bernstein et al. Sep 2011 A1
20110257495 Hoss et al. Oct 2011 A1
20110257895 Brauker et al. Oct 2011 A1
20110263958 Brauker et al. Oct 2011 A1
20110288574 Curry et al. Nov 2011 A1
20110031973 Woodruff et al. Dec 2011 A1
20110319729 Donnay et al. Dec 2011 A1
20110320130 Valdes et al. Dec 2011 A1
20120010642 Lee et al. Jan 2012 A1
20120041291 Ferren et al. Feb 2012 A1
20120078071 Bohm et al. Mar 2012 A1
20120088995 Fennell et al. Apr 2012 A1
20120108931 Taub May 2012 A1
20120108934 Valdes et al. May 2012 A1
20120123690 Wang et al. May 2012 A1
20120157801 Hoss et al. Jun 2012 A1
20120165626 Irina et al. Jun 2012 A1
20120165640 Galley et al. Jun 2012 A1
20120173200 Breton et al. Jul 2012 A1
20120179015 Mann et al. Jul 2012 A1
20120215462 Goode et al. Aug 2012 A1
20120296187 Henning et al. Nov 2012 A1
20130015063 Tsugawa et al. Jan 2013 A1
20130035575 Mayou et al. Feb 2013 A1
20130184547 Taub et al. Jul 2013 A1
20140121480 Budiman et al. May 2014 A1
20150054468 Nikonov Feb 2015 A1
Foreign Referenced Citations (52)
Number Date Country
102307517 Jan 2012 CN
102469941 May 2012 CN
102473276 May 2012 CN
0098592 Jan 1984 EP
0127958 Dec 1984 EP
0320109 Jun 1989 EP
0353328 Feb 1990 EP
0390390 Oct 1990 EP
0396788 Nov 1990 EP
0286118 Jan 1995 EP
1048264 Nov 2000 EP
1153571 Nov 2001 EP
1568309 Aug 2005 EP
1746928 Jan 2012 EP
2652736 Apr 1991 FR
20130067387 Jun 2013 KR
2233111 Jul 2004 RU
WO-1994010560 May 1994 WO
WO-1995031197 Nov 1995 WO
WO-1996025089 Aug 1996 WO
WO-1996035370 Nov 1996 WO
WO-1998017199 Apr 1998 WO
WO-1998043637 Oct 1998 WO
WO-1999047471 Sep 1999 WO
WO-2000049940 Aug 2000 WO
WO-2000059370 Oct 2000 WO
WO-2000074753 Dec 2000 WO
WO-2000075144 Dec 2000 WO
WO-2000078293 Dec 2000 WO
WO-2001052935 Jul 2001 WO
WO-2001054753 Aug 2001 WO
WO-2002016905 Feb 2002 WO
WO-2002039086 May 2002 WO
WO-2002044187 Jun 2002 WO
WO-2003006091 Jan 2003 WO
WO-2003090509 Apr 2003 WO
WO-2003053503 Jul 2003 WO
WO-2003063925 Aug 2003 WO
WO-2003071930 Sep 2003 WO
WO-2003076893 Sep 2003 WO
WO-2003082091 Oct 2003 WO
WO-2003103763 Dec 2003 WO
WO-2004007756 Jan 2004 WO
WO-2004028337 Apr 2004 WO
WO-2006024671 Mar 2006 WO
WO-2007007459 Jan 2007 WO
WO-2008086541 Jul 2008 WO
WO-2008043637 Oct 2008 WO
2010099335 Sep 2010 WO
WO-2010099335 Sep 2010 WO
2012048168 Apr 2012 WO
WO-2010077329 Jul 2012 WO
Non-Patent Literature Citations (69)
Entry
Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526.
Banile, J., et al., Glucose Measurement in Patients with Diabtes Mellitus with Dermal Interstitial Fluid, J. Lab. Clin. Med., vol. 130, No. 4, 1997, pp. 436-431.
Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.
Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.
Bremer, T. M., et al., “Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.
Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56.
Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.
Cheyne, E. H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers”, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613.
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.
Csoregi, E., et al., “Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode”, Analytical Chemistry, vol. 66, No. 19, 1994, pp. 3131-3138.
DIRECNET Study Group, “Accuracy of the Gluco Watch G2 Biographer and the Continuous Glucose Monitoring System During Hyoglycemia”, Diabetes Care, vol. 27, No. 3, 2004, pp. 722-726.
Durand, S., et al., “Current-Induced Vasodilation During Water Iontophoresis (5 min, 0.10 mA) Is Delayed From Current Onset and Involves Aspirin Sensitive Mechanisms”, Journal of Vascular Research, vol. 39, 2002, pp. 59-71.
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired EnzymeTM Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet.
Grossmann, M., et al., “The Effect of Iontophoresis on the Cutaneous Vasculature: Evidence for Current-Induced Hyperemia”, Microvascular Research, vol. 50, 1995, pp. 444-452.
Heller, A., et al., “Amperometric Biosensors Based on Three-Dimensional Hydrogel-Forming Epoxy Networks”, Sensors and Actuators B, vol. 13-14, 1993, pp. 180-183.
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.
Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.
Jobst, G., et al., “Thin-Film Microbiosensors for Glucose-Lactate Monitoring”, Analytical Chemistry, vol. 68, No. 18, 1996, pp. 3173-3179.
Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198.
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, pp. 250.
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.
Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587.
Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.
Maidan, R., et al., “Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors”, Analytical Chemistry, vol. 64, No. 23, 1992, pp. 2889-2896.
Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658.
Mauras, N., et al., “Lack of Accuracy of Continuous Glucose Sensors in Healthy, Nondiabetic Children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy Study,” Journal of Pediatrics, 2004, pp. 770-775.
McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 16 Pages.
McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.
McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532.
Metzger, M., et al., “Reproducibility of Glucose Measurements Using the Glucose Sensor”, Diabetes Care, vol. 25, No. 6, 2002, pp. 1185-1191.
Monsod, T. P., et al., “Do Sensor Glucose Levels Accurately Predict Plasma Glucose Concentrations During Hypoglycemia and Hyperinsulinemia?” Diabetes Care, vol. 25, No. 5, 2002, pp. 889-893.
Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263.
Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301.
Panteleon, A. E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration”, Diabetes Technology & Therapeutics, vol. 5, No. 3, 2003, pp. 401-410.
Parker, R., et al., “Robust H Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.
Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346.
Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217.
Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.
Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161.
Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.
Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.
Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308.
Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.
Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.
Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Sensor”, The Lancet, 1982, pp. 1129-1131.
Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.
Sternberg, R., et al., “Study and Development of Multilayer Needle-Typ Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40.
Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261.
Tsalikian, E., et al., “Accuracy of the GlucoWatch G2® Biographer and the Continuous Glucose Monitoring System During Hypoglycemia: Experience of the Diabetes Research in Children Network”, Diabetes Care, vol. 27, No. 3, 2004, pp. 722-726.
Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115.
Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137.
Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.
Wilson, G. S., et al., “Progress Toward the Development of an Implantable Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.
PCT Application No. PCT/US2014/063316, International Search Report and Written Opinion of the International Searching Authority dated Mar. 24, 2015.
Ali, S., “Finite Element Modeling of Dermally-Implanted Enzymatic Microparticle Glucose Sensors”, Thesis Submitted to the Office of Graduate Studies of Texas A&M University, 2010.
Hanashi, T. et al., “BioCapacitor—A Novel Category of Biosensor,” Biosensors and Bioelectronics, Elsevier BV, NL, vol. 24, No. 7, Mar. 15, 2009, pp. 1837-1842, XP025958941, ISSN: 0956-5663, DOI: 10.1016/J.BIOS.2008.09.014, retrieved on Sep. 24, 2008.
Partial Supplementary European Search Report issued in EP Patent Application No. 14877021.7 dated Aug. 1, 2017.
Office Action issued in corresponding RU Patent Application No. 2016131308 dated Apr. 4, 2018, with English Translation.
Search Report issued in corresponding RU Patent Application No. 2016131308 dated Apr. 4, 2018, with English Translation.
Notification of First Office Action issued in corresponding Chinese Patent Application No. 2014800716857 dated Jun. 27, 2018, includes English Translation.
Hanashi, Takuya et al., “BioCapacitor—A Novel Category of Biosensor,” Biosensors and Bioelectronics, No. 24, pp. 1838-1842, published Sep. 24, 2008.
Related Publications (1)
Number Date Country
20150182153 A1 Jul 2015 US
Provisional Applications (1)
Number Date Country
61922404 Dec 2013 US